These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 20409757)
21. CD137 ligand prevents the development of T-helper type 2 cell-mediated allergic asthma by interferon-gamma-producing CD8+ T cells. Polte T; Jagemann A; Foell J; Mittler RS; Hansen G Clin Exp Allergy; 2007 Sep; 37(9):1374-85. PubMed ID: 17845419 [TBL] [Abstract][Full Text] [Related]
22. Investigating T cell activation and tolerance in vivo: peptide challenge in allergic asthmatics. Smith TR; Larché M Cytokine; 2004 Oct; 28(2):49-54. PubMed ID: 15381180 [TBL] [Abstract][Full Text] [Related]
23. The regulatory role of natural killer T cells in the airways. Umetsu DT; Dekruyff RH Int J Biochem Cell Biol; 2010 Apr; 42(4):529-34. PubMed ID: 19897049 [TBL] [Abstract][Full Text] [Related]
25. Recent progress in the biology of airway dendritic cells and implications for understanding the regulation of asthmatic inflammation. Hammad H; Lambrecht BN J Allergy Clin Immunol; 2006 Aug; 118(2):331-6. PubMed ID: 16890754 [TBL] [Abstract][Full Text] [Related]
26. Modulation of airway inflammation by passive transfer of allergen-specific Th1 and Th2 cells in a mouse model of asthma. Randolph DA; Carruthers CJ; Szabo SJ; Murphy KM; Chaplin DD J Immunol; 1999 Feb; 162(4):2375-83. PubMed ID: 9973518 [TBL] [Abstract][Full Text] [Related]
27. Lipopolysaccharide stimulation of dendritic cells induces interleukin-10 producing allergen-specific T cells in vitro but fails to prevent allergic airway disease. Ahrens B; Freund T; Rha RD; Dittrich AM; Quarcoo D; Hutloff A; Hamelmann E Exp Lung Res; 2009 May; 35(4):307-23. PubMed ID: 19415548 [TBL] [Abstract][Full Text] [Related]
28. Immune mediators in a murine model for occupational asthma: studies with toluene diisocyanate. Matheson JM; Johnson VJ; Luster MI Toxicol Sci; 2005 Mar; 84(1):99-109. PubMed ID: 15590890 [TBL] [Abstract][Full Text] [Related]
29. Regulatory T cell therapy as individualized medicine for asthma and allergy. Xystrakis E; Urry Z; Hawrylowicz CM Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):535-41. PubMed ID: 17989531 [TBL] [Abstract][Full Text] [Related]
30. Reversal of airway hyperresponsiveness by induction of airway mucosal CD4+CD25+ regulatory T cells. Strickland DH; Stumbles PA; Zosky GR; Subrata LS; Thomas JA; Turner DJ; Sly PD; Holt PG J Exp Med; 2006 Nov; 203(12):2649-60. PubMed ID: 17088431 [TBL] [Abstract][Full Text] [Related]
32. The course of allergen-induced leukocyte infiltration in human and experimental asthma. Lommatzsch M; Julius P; Kuepper M; Garn H; Bratke K; Irmscher S; Luttmann W; Renz H; Braun A; Virchow JC J Allergy Clin Immunol; 2006 Jul; 118(1):91-7. PubMed ID: 16815143 [TBL] [Abstract][Full Text] [Related]
33. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. Vijayanand P; Seumois G; Pickard C; Powell RM; Angco G; Sammut D; Gadola SD; Friedmann PS; Djukanovic R N Engl J Med; 2007 Apr; 356(14):1410-22. PubMed ID: 17409322 [TBL] [Abstract][Full Text] [Related]
34. Inflammatory cell distribution in guinea pig airways and its relationship to airway reactivity. Westerhof F; Timens W; van Oosten A; Zuidhof AB; Nauta N; Schuiling M; Vos JT; Zaagsma J; Meurs H; Coers W Mediators Inflamm; 2001 Jun; 10(3):143-54. PubMed ID: 11545251 [TBL] [Abstract][Full Text] [Related]
35. BCG priming of dendritic cells enhances T regulatory and Th1 function and suppresses allergen-induced Th2 function in vitro and in vivo. Ahrens B; Gruber C; Rha RD; Freund T; Quarcoo D; Awagyan A; Hutloff A; Dittrich AM; Wahn U; Hamelmann E Int Arch Allergy Immunol; 2009; 150(3):210-20. PubMed ID: 19494518 [TBL] [Abstract][Full Text] [Related]
36. An Update on Lymphocyte Subtypes in Asthma and Airway Disease. Moldaver DM; Larché M; Rudulier CD Chest; 2017 May; 151(5):1122-1130. PubMed ID: 27818326 [TBL] [Abstract][Full Text] [Related]